D.E. Shaw & Co’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,490
| Closed | -$102K | – | 3344 |
|
2025
Q1 | $102K | Sell |
10,490
-85,762
| -89% | -$837K | ﹤0.01% | 2840 |
|
2024
Q4 | $1.22M | Sell |
96,252
-34,771
| -27% | -$440K | ﹤0.01% | 2052 |
|
2024
Q3 | $2.11M | Buy |
131,023
+17,596
| +16% | +$283K | ﹤0.01% | 1770 |
|
2024
Q2 | $2.77M | Buy |
113,427
+79,659
| +236% | +$1.94M | ﹤0.01% | 1576 |
|
2024
Q1 | $2.43M | Buy |
+33,768
| New | +$2.43M | ﹤0.01% | 1657 |
|
2023
Q3 | – | Sell |
-2,142
| Closed | -$320K | – | 3221 |
|
2023
Q2 | $320K | Sell |
2,142
-9,866
| -82% | -$1.48M | ﹤0.01% | 2474 |
|
2023
Q1 | $1.76M | Sell |
12,008
-3,830
| -24% | -$562K | ﹤0.01% | 1916 |
|
2022
Q4 | $2.51M | Buy |
15,838
+3,403
| +27% | +$539K | ﹤0.01% | 1898 |
|
2022
Q3 | $2.39M | Buy |
+12,435
| New | +$2.39M | ﹤0.01% | 2005 |
|
2022
Q1 | – | Sell |
-8,581
| Closed | -$2.52M | – | 4437 |
|
2021
Q4 | $2.52M | Sell |
8,581
-7,390
| -46% | -$2.17M | ﹤0.01% | 2230 |
|
2021
Q3 | $3.97M | Buy |
15,971
+9,986
| +167% | +$2.48M | ﹤0.01% | 1634 |
|
2021
Q2 | $1.52M | Buy |
+5,985
| New | +$1.52M | ﹤0.01% | 2261 |
|